A detailed history of Lecap Asset Management LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 2,438 shares of BIO stock, worth $670,157. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,438
Previous 4,925 50.5%
Holding current value
$670,157
Previous $1.59 Billion 46.97%
% of portfolio
0.18%
Previous 0.58%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$304.11 - $351.99 $756,321 - $875,399
-2,487 Reduced 50.5%
2,438 $843 Million
Q4 2023

Jan 29, 2024

BUY
$269.37 - $365.04 $1.33 Million - $1.8 Million
4,925 New
4,925 $1.59 Billion

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.77B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.